Lidia Atripaldi
Dados Biográficos
| ID | 7864752 |
|---|---|
| NOME | Lidia Atripaldi |
| PRENOMES | Lidia |
| SOBRENOME | Atripaldi |
| ASSINATURA | ATRIPALDI L |
| AFILIAÇÕES | Ospedale Monaldi |
| ORCID | 0000-0003-4370-7682 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2021 |
| ÍNDICE H | 0 |
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
Sem obras proeminentes nesta página.
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with Covid-19 Pneumonia
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolme…
Atypical pneumonia (1 obra) · Coronavirus disease 2019 (COVID-19 (1 obra) · Dermatological and COVID-19 studies (1 obra) · Disease (1 obra) · Gastroenterology (1 obra) · Immunology (1 obra) · Inhalation and Respiratory Drug Delivery (1 obra) · Internal Medicine (1 obra) · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 obra) · Medicine (1 obra)